Literature DB >> 22561038

Screening history preceding a diagnosis of cervical cancer in women age 65 and older.

Helen Dinkelspiel1, Barbara Fetterman, Nancy Poitras, Walter Kinney, J Thomas Cox, Thomas Lorey, Philip E Castle.   

Abstract

OBJECTIVE: To characterize the antecedent screening of women 65 years of age and older diagnosed with cervical cancer.
METHODS: Screening histories of women 65 years of age and older who were diagnosed with cervical cancer between 2003 and 2008 were examined utilizing the organization's databases and the regional Cancer Registry. Stopping screening was recommended at age 65 for members who had either 3 consecutive negative Paps or a single negative Pap plus HPV test ("cotest").
RESULTS: From 2003 through 2008 there were 56 Kaiser Permanente Northern California members 65 years of age and older diagnosed with cervical cancer. During the same time period there were 1,323,100 woman-years of membership in women age 65 and older. The risk of invasive cancer among women age 65 and older was 4.2/100,000/year in 2003-2008. 33 of 56 (59%) had one or more Pap smears prior to diagnosis. Of the 33, 14 women (25%) had 3 consecutive negative Pap smears prior to diagnosis. Three of 46,401 women with 1 or more negative cotests at age 65 and older were subsequently diagnosed with invasive cancer during 132,639 women-years of follow-up (2.3/100,000/year).
CONCLUSIONS: Most cervical cancers diagnosed at age 65 and older occur in women who have not met our criteria for stopping screening. A few cancers will continue to occur at age 65 and older despite multiple negative tests, as is true in other age groups. We currently have no evidence that these cancers would be prevented with continued screening at ages 65 and older.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22561038     DOI: 10.1016/j.ygyno.2012.04.037

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

1.  Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults.

Authors:  Jennifer L Moss; Siddhartha Roy; Chan Shen; Joie D Cooper; Robert P Lennon; Eugene J Lengerich; Alan Adelman; William Curry; Mack T Ruffin
Journal:  JAMA Netw Open       Date:  2020-07-01

2.  Using the Cancer Risk Management Model to evaluate the health and economic impacts of cytology compared with human papillomavirus DNA testing for primary cervical cancer screening in Canada.

Authors:  C Popadiuk; C L Gauvreau; M Bhavsar; C Nadeau; K Asakawa; W M Flanagan; M C Wolfson; A J Coldman; S Memon; N Fitzgerald; J Lacombe; A B Miller
Journal:  Curr Oncol       Date:  2016-02-29       Impact factor: 3.677

Review 3.  Screening for Cervical Cancer.

Authors:  Terresa J Eun; Rebecca B Perkins
Journal:  Med Clin North Am       Date:  2020-11       Impact factor: 5.456

4.  Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.

Authors:  Katie E Lichter; Kimberly Levinson; Anne Hammer; Melissa H Lippitt; Anne F Rositch
Journal:  Gynecol Oncol       Date:  2022-02-01       Impact factor: 5.482

5.  Frequency of high-grade squamous cervical lesions among women over age 65 years living with HIV.

Authors:  L Stewart Massad; Xianhong Xie; Howard L Minkoff; Katherine G Michel; Gypsyamber D'Souza; Chia-Ching Wang; Deborah Konkle-Parker; Igho Ofotokun; Margaret A Fischl; Lisa Rahangdale; Howard D Strickler
Journal:  Am J Obstet Gynecol       Date:  2021-05-03       Impact factor: 10.693

Review 6.  It's time to re-evaluate cervical Cancer screening after age 65.

Authors:  Sarah Dilley; Warner Huh; Batel Blechter; Anne F Rositch
Journal:  Gynecol Oncol       Date:  2021-04-26       Impact factor: 5.304

7.  Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.

Authors:  Alejandra Castañón; Rebecca Landy; Jack Cuzick; Peter Sasieni
Journal:  PLoS Med       Date:  2014-01-14       Impact factor: 11.069

8.  Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study.

Authors:  Amelia Acera; Josep Maria Manresa; Diego Rodriguez; Ana Rodriguez; Josep Maria Bonet; Norman Sanchez; Pablo Hidalgo; Pilar Soteras; Pere Toran; Marta Trapero-Bertran; Iris Lozano; Silvia De Sanjose
Journal:  BMC Womens Health       Date:  2014-07-16       Impact factor: 2.809

9.  Evidence of disrupted high-risk human papillomavirus DNA in morphologically normal cervices of older women.

Authors:  Sarah M Leonard; Merlin Pereira; Sally Roberts; Kate Cuschieri; Gerard Nuovo; Ramanand Athavale; Lawrence Young; Raji Ganesan; Ciarán B Woodman
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

10.  Cost-effectiveness of strategies to increase screening coverage for cervical cancer in Spain: the CRIVERVA study.

Authors:  Marta Trapero-Bertran; Amelia Acera Pérez; Silvia de Sanjosé; Josep Maria Manresa Domínguez; Diego Rodríguez Capriles; Ana Rodriguez Martinez; Josep Maria Bonet Simó; Norman Sanchez Sanchez; Pablo Hidalgo Valls; Mireia Díaz Sanchis
Journal:  BMC Public Health       Date:  2017-02-14       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.